Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies

被引:25
作者
Nyberg, S [1 ]
Farde, L [1 ]
机构
[1] Karolinska Hosp, Psychiat Sect, Dept Clin Neurosci, S-17176 Stockholm, Sweden
关键词
D O I
10.1007/s002130050020
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:22 / 23
页数:2
相关论文
共 18 条
[1]   Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].
Beasley, CM ;
Tollefson, G ;
Tran, P ;
Satterlee, W ;
Sanger, T ;
Hamilton, S ;
Fabre, L ;
Small, J ;
Ereshefsky, L ;
True, J ;
Nemeroff, C ;
Risch, SC ;
Perry, PJ ;
Potkin, SG ;
Borison, RL ;
James, S ;
Meltzer, HY ;
Iqbal, N ;
Fann, WE ;
Gewirtz, GR ;
Landbloom, R ;
RoyByrne, PP ;
Tuason, VB ;
Carman, JS ;
Stokes, PE ;
Williams, R ;
Ancill, RJ ;
MacEwan, GW ;
Gujavarty, KS ;
Jones, B ;
Lohr, JB .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123
[2]   D1-DOPAMINE AND D2-DOPAMINE RECEPTOR OCCUPANCY DURING TREATMENT WITH CONVENTIONAL AND ATYPICAL NEUROLEPTICS [J].
FARDE, L ;
WIESEL, FA ;
NORDSTROM, AL ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1989, 99 :S28-S31
[3]  
FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71
[4]  
FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538
[5]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[6]  
Kapur S, 1996, AM J PSYCHIAT, V153, P948
[7]   ORAL-ADMINISTRATION OF NNC-756 - A PLACEBO-CONTROLLED PET STUDY OF D-1-DOPAMINE RECEPTOR OCCUPANCY AND PHARMACODYNAMICS IN MAN [J].
KARLSSON, P ;
FARDE, L ;
HALLDIN, C ;
SEDVALL, G ;
YNDDAL, L ;
SLOTHNIELSEN, M .
PSYCHOPHARMACOLOGY, 1995, 119 (01) :1-8
[8]  
MARDER SR, 1994, AM J PSYCHIAT, V151, P825
[9]  
MCEVOY JP, 1991, ARCH GEN PSYCHIAT, V48, P739
[10]   Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients [J].
Nordström, AL ;
Nyberg, S ;
Olsson, H ;
Farde, L .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (03) :283-284